Figure 1From: Psoriasis vulgaris flare during efalizumab therapy does not preclude future use: a case seriesClinical photos of patient 1 during the flare reaction in June 2004 (upper panels), with follow-up photos after standard-dose treatment with efalizumab for three months (lower panels).Back to article page